Hand bone densitometry: A more sensitive standard for the assessment of early bone damage in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1513-1517

  Haugeberg, Glenn ^b,c   Green, Michael J ^d   Conaghan, Philip G ^d   Quinn, Mark ^d   Wakefield, Richard ^d   Proudman, Susanna M ^e   Stewart, Sheena ^d   Hensor, Elizabeth ^d   Emery, Paul ^a,d,e  

^a CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^b Department of Rheumatology Sørlandet Hospital ^*  (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; BONE DENSITY; BONE INJURY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAND BONE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OSTEOLYSIS; PRIORITY JOURNAL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; ARTHRITIS, RHEUMATOID; BONE DENSITY; DENSITOMETRY, X-RAY; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; FEMUR NECK; FOLLOW-UP STUDIES; HAND BONES; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 35648953371     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.067652     Document Type: Article

References (33)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
2. Haugeberg G, Emery P. Value of dual-energy x-ray absorptiometry as a diagnostic and assessment tool in early rheumatoid arthritis. Rheum Dis Clin North Am 2005;31:715-28.
3. Green MJ, Deodhar AA. Bone changes in eaHy rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001;15:105-23.
4. van der Heijde DM. Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis. Rheumatology 2000;39(Suppl 1):9-16.
5. Drossaers-Bakker KW, de Buck M, Van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999;42:1854-60.
6. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with eady rheumatoid arthritis. Lancet 1994;344:23-7.
7. Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD. Longitudinal study of hand bone densitometry in rheumatoid arthritis. Arthritis Rheum 1995;38:1204-10.
8. Haugeberg G, Green MJ, Quinn MA, Marzo-Ortega H, Proudman S, Karim Z, et al. Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 2006;65:736-40.
9. Emery P. The Dunlop-Dottridge Lecture: prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy. J Rheumatol 1997;24:1436-42.
10. Proudman SM, Conaghan PG, Richardson C, Griffiths B, Green MJ, McGonagle D, et al. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 2000;43:1809-19.
11. Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD. Measurement of hand bone mineral content by dual energy x-ray absorptiometry: development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis. Ann Rheum Dis 1994;53:685-90.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
13. Lodder MC, Lems WF, Ader HJ, Marthinsen AE, van Coeverden SC, Lips P, et al. Reproducibility of bone mineral density measurement in daily practice. Ann Rheum Dis 2004;63:285-9.
14. Ravaud P, Reny JL, Giraudeau B, Porcher R, Dougados M, Roux C. Individual smallest detectable difference in bone mineral density measurements. J Bone Miner Res 1999;14:1449-56.
15. Bruynesteyn K, Boers M, Kostense P, Van Der LS, Van Der HD. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Ann Rheum Dis 2005;64:179-82.
16. Genant HK, Block JE, Steiger P, Glueer CC, Ettinger B, Harris ST. Appropriate use of bone densitometry. Radiology 1989;170:817-22.
17. Gluer CC. Monitoring skeletal changes by radiological techniques. J Bone Miner Res 1999;14:1952-62.
18. Van Der HD. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999;26:743-5.
19. Lassere MN, van der Heijde D, Johnson K, Bruynesteyn K, Molenaar E, Boonen A, et al. Robustness and generalizability of smallest detectable difference in radiological progression. J Rheumatol 2001;28:911-13.
20. Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J. Detailed anafysesin periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int 2000;11:400-7.
21. Paulus HE, Oh M, Sharp JT, Gold RH, Wong WK, Park GS, et al. Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis. J Rheumatol 2003;30:705-13.
22. van der Heijde D. Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment? Ann Rheum Dis 2001;60(Suppl III):47-50.
23. Deodhar AA, Brabyn J, Pande I, Scott DL, Woolf AD. Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker. Ann Rheum Dis 2003;62:767-70.
24. Lindqvist E, Jonsson K, Saxne T, Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 2003;62:611-16.
25. Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield PJ, Gibbon WW, et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003;48:64-71.
26. McQueen F, Lassere M, Edmonds J, Conaghan P, Peterfy C, Bird P, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERAQ 6 MR Imaging Module. J Rheumatol 2003;30:1387- 92.
27. Wakefield RJ, Gibbon WW, Conaghan PG, O'Connor P, McGonagle D, Pease C, et al. The value of sonography in the detection of bone erosions in patients with nheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 2000;43:2762-70.
28. Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, et al. Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 2002;46:785-92.
29. Gravallese EM, Goldring SR. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 2000;43:2143-51.
30. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999;25:255-9.
31. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000;275:768-75.
32. Schett G, Redlich K, Hayer S, Zwerina J, Bolon B, Dunstan C, et al. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum 2003;48:2042-51.
33. Jarrett SJ, Conaghan PG, Sloan VS, Papanastasiou P, Ortmann CE, O'Connor PJ, et al. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 2006;54:1410-14.